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zrin, radixin, and moesin (ERM) regulate cortical
morphogenesis and cell adhesion by connecting
membrane adhesion receptors to the actin-based cy-
toskeleton. We have studied the interaction of moesin and
ezrin with the vascular cell adhesion molecule (VCAM)-1
during leukocyte adhesion and transendothelial migration
(TEM). VCAM-1 interacted directly with moesin and ezrin
 
in vitro, and all of these molecules colocalized at the api-
cal surface of endothelium. Dynamic assessment of this
interaction in living cells showed that both VCAM-1
and moesin were involved in lymphoblast adhesion and
spreading on the endothelium, whereas only moesin
participated in TEM, following the same distribution pattern
E
 
as ICAM-1. During leukocyte adhesion in static or under
ﬂow conditions, VCAM-1, ICAM-1, and activated moesin
and ezrin clustered in an endothelial actin-rich docking
structure that anchored and partially embraced the leukocyte
containing other cytoskeletal components such as 
 
 
 
-actinin,
vinculin, and VASP. Phosphoinositides and the Rho/p160
ROCK pathway, which participate in the activation of ERM
proteins, were involved in the generation and maintenance
of the anchoring structure. These results provide the ﬁrst
characterization of an endothelial docking structure that
plays a key role in the ﬁrm adhesion of leukocytes to the
endothelium during inﬂammation.
 
Introduction
 
Leukocyte extravasation across the endothelial barrier is a
fundamental requirement in a wide variety of physiological
and pathological scenarios, including immunity and inflamma-
tion. This phenomenon is an active, multistep process that
requires drastic morphological changes involving cytoskeletal-
directed clustering of adhesion receptors in both leukocytes
and endothelial cells (Butcher, 1991). Among adhesion
receptors, the integrins 
 
 
 
4
 
 
 
1 (VLA-4) and 
 
 
 
L
 
 
 
2 (LFA-1)
play a major role in the tight adhesion of leukocytes to en-
dothelium (González-Amaro and Sánchez-Madrid, 1999).
Their main ligands on endothelium are vascular cell adhesion
molecule (VCAM)*-1 and intercellular adhesion molecule
(ICAM)-1, respectively (Marlin and Springer, 1987; Elices
et al., 1990). ICAM-1 but not VCAM-1 is basally expressed
in resting cells, and both molecules are induced upon activation
by proinflammatory cytokines such as IL-1 and TNF-
 
 
 
(Carlos and Harlan, 1994). Although it has been described
that both VLA-4/VCAM-1 and LFA-1/ICAM-1 interactions
mediate the firm adhesion of leukocytes, only the latter
molecular pair seems to be required for lymphocyte diapedesis
(Oppenheimer-Marks et al., 1991).
The interaction of adhesion molecules with cytoskeletal
components is of critical importance for cell–cell and cell–
substratum adhesion as well as for receptor internalization.
The cortical cytoskeleton regulates the membrane localization
of several adhesion receptors, such as ICAMs, CD43, and
CD44, through one or more members of the ezrin, radixin,
and moesin (ERM) family of proteins (Serrador et al., 1997;
Heiska et al., 1998; Yonemura et al., 1998). These molecules
function as membrane-actin cytoskeleton linkers regulating
cortical morphogenesis and cell adhesion. Accordingly, they
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play a key role in the formation of protrusive plasma mem-
brane structures such as filopodia, microspikes, or microvilli
(Mangeat et al., 1999; Yonemura and Tsukita, 1999). Struc-
turally, they are closely related to each other and seem to be
functionally redundant, as suggested by the apparently normal
phenotype of moesin knockout mice (Doi et al., 1999). Their
NH
 
2
 
-terminal domains interact with integral membrane pro-
teins, whereas their COOH-terminal domains bind F-actin
(Turunen et al., 1994). These functions are conformationally
regulated by reversible changes from inactive to functionally
active forms. Binding of phosphatidylinositol 4,5-biphosphate
 
(
 
PI[4,5]P
 
2
 
) and phosphorylation of a specific COOH-terminal
threonine residue unmask the F-actin and membrane binding
sites and stabilize the active conformation (Nakamura et al.,
1999; Barret et al., 2000). The Rho/p160 ROCK signaling
pathway and the phosphatidylinositol turnover are the major
regulatory mechanisms for ERM activation, inducing their
phosphorylation and translocation into apical membrane/actin
protrusions (Hirao et al., 1996; Matsui et al., 1998; Shaw et
al., 1998). On the other hand, activated ERM proteins can se-
questrate Rho-GDI to permit Rho activation, providing a pos-
itive feedback pathway (Takahashi et al., 1997).
These proteins have been studied in a variety of cellular
types, but thus far their functions have not been addressed in
endothelial cells. Herein, we describe the direct interaction
of VCAM-1 with moesin and ezrin, the two members of the
ERM family most highly expressed in endothelium (Me-
nager et al., 1999). We also describe the dynamic distri-
bution of VCAM-1, ICAM-1, and moesin during leuko-
cyte adhesion and lymphoblast transendothelial migration
(TEM), using live time-lapse fluorescence confocal micros-
copy. Our data indicate that an endothelial docking struc-
ture is formed during leukocyte-endothelium interaction in
static and under flow conditions. VCAM-1, ICAM-1, and
activated ERM proteins participate in this novel anchoring
structure together with structural and regulatory molecules
typical of nascent phagosomes.
 
Results
 
VCAM-1 interacts with moesin and ezrin at the apical 
surface of activated endothelial cells
 
The subcellular distribution of VCAM-1, ezrin, and moesin,
was analyzed by confocal microscopy in TNF-
 
 
 
–activated
human umbilical vein endothelial cells (HUVEC). VCAM-1
colocalized with ezrin (Fig. 1, a–c) and moesin (Fig. 1, e–g)
in the microspikes and microvilli that protrude from the api-
cal surface of these cells. Colocalization analysis confirmed
these observations (Fig. 1, d and h). By contrast, VE-cad-
herin did not colocalize with ERM proteins (Fig. 1, i–l).
To assess whether this codistribution in activated HUVEC
is correlated with the formation of complexes between
VCAM-1 molecules and ERM proteins, immunoprecipita-
tion assays were performed. As shown in Fig. 2 A, moesin and
ezrin coimmunoprecipitated with VCAM-1. To determine
whether these interactions are direct, binding assays were per-
formed using a glutathione-
 
S
 
-transferase (GST) fusion pro-
tein containing the cytoplasmic tail of VCAM-1 (GST–VC).
The fusion protein containing the cytoplasmic tail of ICAM-3,
GST–IC3, which has been demonstrated to bind ERM, as
Figure 1.  VCAM-1 colocalizes with 
moesin and ezrin at the apical surface 
of activated HUVEC. Confluent HUVEC 
were activated with 20 ng/ml TNF-  for 
20 h. Thereafter, cells were fixed, 
permeabilized, and stained with the 
anti-ezrin pAb 90/3 (a and i, green), 
anti-moesin pAb 95/2 (e, green), anti–
VCAM-1 mAb P8B1 (b and f, red), or 
anti–VE-cadherin mAb Tea1/31 (j, red). 
Merged images are shown in c, g, and k, 
where colocalizations are observed 
(yellow). Images represent confocal laser 
scanning micrographs showing horizontal 
projections or the corresponding 
orthogonal section of the same field. 
Insets correspond to the amplified image 
of the zones pointed to by arrows. 
Colocalization histograms of green and 
red signals corresponding to these images 
are shown on the right (d, h, and l). The 
corresponding colocalization percentages 
are 65.7% (d), 67.6% (h), and 13.3% (l). 
Bar, 20  m. 
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well as the partially truncated form GST-Y9, which shows a
considerable reduced binding to moesin and ezrin (Serrador et
al., 2002), were used as positive and negative controls, respec-
tively. 
 
35
 
S-Met–labeled NH
 
2
 
-terminal domain of moesin,
N-moesin, and the NH
 
2
 
-terminal domain of ezrin, N-ezrin,
were added to Sepharose beads coupled to the GST fusion
proteins. Strong binding of VCAM-1 to ezrin and moesin was
observed, which was much higher in comparison to ICAM-3
(Fig. 2 B). Altogether, these data demonstrate that VCAM-1
can directly associate with ezrin and moesin in vitro and pre-
sumably also at the apical membrane sites of endothelial cells.
 
Differential contribution of VCAM-1, ICAM-1, and 
ERM proteins to the extravasation process
 
The functional role of the VCAM-1/ERM association in the
endothelial cell–lymphocyte interaction was analyzed and
compared with another adhesion receptor that also interacts
with ERM proteins, namely ICAM-1 (Heiska et al., 1998).
For this purpose, we used T lymphoblasts, that express high
levels of VLA-4 and LFA-1, ligands of VCAM-1 and ICAM-1,
respectively (Fig. 3 A). Both integrins were active since mAb
against them blocked T lymphoblast TEM (Fig. 3 B). These
cells were allowed to adhere and migrate across an activated
HUVEC monolayer and confocal microscopic analysis of
endogenous endothelial VCAM-1 and ICAM-1 distribution
was performed. When lymphoblasts were spread on the api-
cal surface of endothelium, VCAM-1 clustered around these
cells (Fig. 3 C, a). However, such VCAM-1 clusters were
neither observed during the passage of lymphoblasts across
the endothelium nor after transmigration (Fig. 3 C, b). The
orthogonal section showed two lymphoblasts migrating
across adjacent endothelial cells, where clustered VCAM-1
molecules colocalized with endothelial ezrin only at the api-
cal surface of the lymphoblast-endothelial cell contact area
(Fig. 3 C, c). On the other hand, ICAM-1 was clustered
around lymphoblasts during all the lymphoblast adhesion
and transmigration processes (Fig. 3 C, d and e), colocaliz-
ing with endothelial ezrin (Fig. 3 C, f).
To dynamically assess the changes in distribution of
VCAM-1, ICAM-1, and ERM proteins, HUVEC transiently
transfected with VCAM-1–, ICAM-1–, or moesin–green flu-
orescent protein (GFP) were separately monitored by live
Figure 2.  Association of VCAM-1 
with moesin and ezrin. (A) Cytokine-
activated HUVEC were lysed and 
immunoprecipitated with the anti–
VCAM-1 mAb 4B9 or Gly-Sepharose. 
Immunoprecipitates were then resolved 
on a 10% SDS-PAGE, and sequentially 
immunoblotted with the anti-VCAM-1 
mAb 4B9, the anti-moesin pAb 95/2, 
and the anti-ezrin pAb 90/3. Molecular 
weights (kD) are indicated on the right 
side. (B) GST or the GST fusion proteins 
GST–VC, GST–IC3 and GST–Y9 were 
bound to glutathione-Sepharose beads 
and incubated with 
35S-Met-N-moesin or 
35S-Met-N-ezrin (top and bottom, 
respectively). After incubation, beads 
were boiled in sample buffer and eluted 
proteins were analyzed by 10% 
SDS-PAGE, autoradiography, and 
fluorography. Lanes with isotope-labeled 
N-moesin and N-ezrin (*) indicate the 
molecular mass of these truncated 
proteins. Densitometric diagrams 
normalized to the loading controls of 
GST proteins are shown on the right. 
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time-lapse confocal microscopy after addition of lympho-
blasts. As observed previously for endogenous molecules,
VCAM-1– and moesin–GFP fusion proteins redistributed to
sites of contact during lymphoblast initial adhesion and
spreading. However, only moesin was concentrated in the
transmigration cleft and apparently participated in subse-
quent interactions, when lymphoblasts migrated beneath the
activated endothelium (Fig. 4 A). Interestingly, moesin–GFP
exhibited a dynamic behavior similar to ICAM-1–GFP (Fig.
4 B), presumably because this adhesion molecule binds to
ERM proteins to actively participate in TEM. Digital movies
showing more clearly the differential dynamic distribution of
these molecules are included as additional material.
 
Redistribution of VCAM-1, ICAM-1, and 
ERM proteins at a docking structure during 
endothelium–leukocyte interaction
 
To focus our study on the role of ERM interaction with endo-
thelial adhesion receptors during the initial adhesion of leuko-
cytes to the endothelium, to which VCAM-1 involvement was
mainly restricted, we used K562 cells stably transfected with
 
 
 
4 integrin (4M7 cells) (Muñoz et al., 1996). These cells ex-
pressed high levels of VLA-4, but negligible amounts of LFA-1
(Fig. 5 A). In addition, their adhesion to activated endothe-
lium was dependent on VLA-4, as it was inhibited by the
blocking anti-
 
 
 
4 HP2/1 mAb, and induced by the activating
anti-
 
 
 
1 TS2/16 mAb (Fig. 5 B). 4M7 cells adhered to acti-
vated endothelium mainly via VLA-4, but these cells were un-
able to progress to TEM (unpublished data). When the distri-
bution of endogenous endothelial VCAM-1 was examined
during 4M7 cell adhesion, we found that it was strongly con-
centrated around attached leukocytes (Fig. 5 C, c). Endoge-
nous ezrin colocalized with VCAM-1 at the endothelial–leuko-
cyte contact area (Fig. 5 C, d), and antibodies to ezrin also
stained the leukocyte membrane (Fig. 5 C, b). Furthermore, a
three-dimensional reconstruction of the site of adhesion
showed that VCAM-1 and ezrin were contained in a unique
docking structure that was raised above the level of the endo-
Figure 3.  Distribution of endogenous VCAM-1, ICAM-1, and ezrin during lymphoblast TEM. (A) Expression of  4-integrin (thick line), and 
 L-integrin (thin line) on T lymphoblasts as determined by flow cytometry analysis. P3 63 (dotted line) was used as negative control. 
(B) Transendothelial migration assay of T lymphoblasts pretreated with the blocking anti- 4 mAb HP2/1, the blocking anti- L mAb TS1/11, 
the mixture of anti- 4 plus  L mAb, or the anti–ICAM-3 mAb TP1/24 as negative control. Values correspond to the arithmetic mean   SD of 
a representative experiment run by duplicate out of three independent ones. Statistically significant values, as defined by unpaired Student’s t 
test, are indicated with * (P   0.05) or ** (P   0.015) compared with no mAb treatment. (C) T lymphoblasts were allowed to transmigrate 
across an activated HUVEC monolayer, and then cells were fixed, permeabilized, and stained with the anti–VCAM-1 mAb P8B1 (a–c, red), 
the anti-ICAM-1 mAb Hu5/3 (d–f, red), or the anti-ezrin pAb 90/3 (c and f, green). Representative confocal horizontal images showing an 
apical section of endothelium with adhered lymphoblasts on top (a and d) and a basal section with transmigrated lymphoblasts beneath the 
endothelium (b and e) are presented.  DIC images are shown overlaid with VCAM-1 (a and b) or ICAM-1 staining (d and e). Arrows point to 
VCAM-1 or ICAM-1 clusters at the contact area. Representative orthogonal sections corresponding to the white line in panel a or panel d are 
shown in panels c and f, respectively. Green signal corresponds to ezrin staining both in lymphoblasts and endothelium. Arrowheads point to 
the sites of VCAM-1/ezrin or ICAM-1/ezrin clustering at the apical surface of endothelial cells. Bars: (a and b) 20  m; (d and e) 8  m. 
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Figure 4.  Dynamic changes in the localization of VCAM-1, ICAM-1, and 
moesin during lymphoblast TEM. (A) Lymphoblasts were allowed to transmigrate 
across activated HUVEC transfected with moesin- or VCAM-1–GFP. Video 
sequences tracking the spatial and temporal distribution of moesin (a–f) and 
VCAM-1 (g–l) were obtained using live time-lapse fluorescence confocal 
microscopy. Each image represents a projection of several representative 
horizontal sections of a confocal image stack depicted from the video 
sequence at the specified times. DIC and fluorescence images are merged and 
presented at the lower side of each panel. Arrows point to the GFP proteins 
clustering during the lymphoblast–endothelium interaction. Arrowheads 
indicate the absence of VCAM-1–GFP from the contact area between the 
transfected endothelial cell and a migrated lymphoblast placed beneath the 
endothelial monolayer. Corresponding digital video sequences are available 
at http://www.jcb.org/cgi/content/full/jcb.200112126/DC1. Bars, 20  m. 
(B) Lymphoblast transmigration across activated HUVEC transfected with 
ICAM-1–GFP was analyzed by live time-lapse fluorescence confocal microscopy. 
Two representative horizontal sections from the apical and the basal side of 
the endothelial cell belonging to the same confocal stack depicted from the 
video sequence are presented. ICAM-1–GFP signal is shown in panels a and 
d. DIC images and the overlaid images are presented in panels b and e, and c 
and f, respectively. The corresponding video sequence is available at http://
www.jcb.org/cgi/content/full/jcb.200112126/DC1. Bar, 5  m.  
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thelial cell surface and that surrounded the adherent leukocyte
in a cup-like fashion. Both proteins were preferentially concen-
trated in microspikes of this structure that presumably served
to anchor the attached leukocyte (Fig. 5 C, e–g). The redistri-
bution of VCAM-1 and moesin to the leukocyte–endothelium
contact area was tracked separately by live time-lapse fluores-
cence confocal microscopy during the interaction of 4M7 cells
with VCAM-1– or moesin–GFP transfected HUVEC. The
dynamic studies demonstrated that VCAM-1/VLA-4 engage-
ment was associated with the progressive concentration of
VCAM-1 and moesin at the specialized anchoring structure
formed between the two interacting cells, which was progres-
sively strengthened and sustained with time (Fig. 5 D).
To ascertain the physiological relevance of this dock-
ing structure, we analyzed the redistribution of VCAM-1,
ICAM-1, and ezrin to the contact area of migrating periph-
eral blood lymphocytes (PBLs) allowed to adhere under
fluid shear conditions, using a physiological wall shear stress
(1.8 dyn/cm
 
2
 
) for perfusion periods from 30 s to 10 min.
We found these endothelial molecules colocalizing in clus-
ters at the docking structures formed around spread PBLs
(Fig. 6 A), at early time points during the arrest of lympho-
cytes. This structure was also observed during the interac-
tion of activated HUVEC with T lymphoblasts in static
conditions (Fig. 6 B; unpublished data). Similarities in
three-dimensional VCAM-1 distribution around 4M7 cells,
T lymphoblasts or peripheral blood lymphocytes supported
the generality of the docking structure (Fig. 6 B).
 
Relocation of cytoskeletal components to the 
endothelial docking structure
 
The cytoskeletal components involved in the generation of
this endothelial structure were analyzed. Samples of 4M7
cells adhered to activated HUVEC and stained for VCAM-1
and F-actin revealed a considerable enrichment of endothe-
lial actin within the docking structure (Fig. 7 A, a–b). Inter-
estingly, this apical actin scaffold appeared not to be con-
nected to basal stress fibers (Fig. 7 A, c–d). On the contrary,
tubulin was not present with F-actin at the anchoring struc-
ture (Fig. 7 A, e–h). Vinculin and 
 
 
 
-actinin–GFP also redis-
tributed to this structure with a punctuate pattern (Fig. 7 B,
c and d, and C, a–c). Likewise, VASP-GFP colocalized with
VCAM-1 (Fig. 7 C, f–g), whereas talin and paxillin-GFP
were only found colocalizing with VCAM-1 at some adhe-
sion structures (Fig. 7 B, a and b, and C, d and e). These
data indicate that the endothelial docking structure was sup-
ported by the actin cytoskeleton, actin bundling proteins
such as 
 
 
 
-actinin, actin-nucleating proteins such as VASP,
and focal adhesion proteins such as vinculin, talin or paxil-
lin. The formation of this structure was associated with a re-
markable change in distribution of several of these proteins,
in particular vinculin, talin, and paxillin, from their normal
Figure 5.  Localization of VCAM-1 and 
ezrin at the contact area of activated 
HUVEC with leukocytes. (A) Expression of 
 4-integrin (thick line), and  L-integrin 
(thin line) on 4M7 cells as determined by 
flow cytometry analysis. P3 63 (dotted 
line) was used as negative control. 
(B) Adhesion to activated HUVEC of 4M7 
cells pretreated with the blocking anti- 4 
mAb HP2/1, the activating anti-b1 mAb 
TS2/16, or the blocking anti- L mAb 
TS1/11. Values correspond to the 
arithmetic mean   SD of a representative 
experiment run by triplicate out of three 
independent ones. Statistically significant 
values, as defined by unpaired Student’s t 
test, are indicated with * (P   0.005) or 
** (P   0.0001), compared with no mAb 
treatment. (C) 4M7 cells interacting with 
activated endothelial cells were fixed, 
permeabilized, and stained with the 
anti-ezrin pAb 90/3 (green) and the anti–
VCAM-1 mAb P8B1 (red). Representative 
horizontal sections of confocal laser 
scanning images (b and c) are merged in d. 
The corresponding DIC image is shown in 
a. The corresponding three-dimensional 
reconstruction is presented in e–g. Bar, 5 
 m. (D) 4M7 cells were allowed to adhere 
to activated HUVEC transfected with 
moesin- or VCAM-1–GFP. GFP staining 
was monitored using live time-lapse 
fluorescence confocal microscopy. 
Horizontal sections showing the staining 
of moesin- (a) or VCAM-1–GFP (b) after 60 
min of leukocyte–endothelium interaction. 
Arrows point to the GFP proteins clustered 
in the anchoring structure. Bar, 20  m. 
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subcellular localization at focal adhesions at the basal surface
to the docking structure at the apical surface.
 
The docking structure is regulated by PI(4,5)P
 
2
 
 and 
Rho/p160 ROCK
 
To assess whether the clustering of ERM proteins at the en-
dothelial-leukocyte contact area is associated with an acti-
vated state of these proteins, immunofluorescence studies
using the 297S mAb, which recognizes a COOH-terminal
threonine phosphorylated in ERM proteins (Matsui et al.,
1998), were conducted in the 4M7 cell adhesion model. A
high concentration of phosphorylated ERM proteins was
evident at the endothelial anchoring structure generated
after VCAM-1/VLA-4 interaction (Fig. 8 A). We have also
studied two important regulators of ERM activation,
namely phosphoinositides and components of the Rho/p160
ROCK pathway. The subcellular localization of different
phosphoinositides was determined by using as probes the
PH domain of PLC
 
 
 
, which binds PI(4,5)P
 
2
 
, and that of
GRP1, which binds PI(3,4,5)P
 
3
 
 and PI(3,4)P
 
2
 
, fused to
GFP (Gray et al., 1999; Várnai et al., 1999). Upon endothe-
lial cell transfection, both probes colocalized with VCAM-1
at the endothelial docking structure (Fig. 8 B, a and b; d
and e). PLC
 
 
 
-PH–GFP showed a higher concentration
at microspike tips (Fig. 8 B, c), whereas GRP1-PH–GFP
appeared to be more diffusely distributed and localized
throughout the entire structure (Fig. 8 B, f).
Next, blocking studies with chemical inhibitors were per-
formed before and after HUVEC-4M7 cell adhesion. The
p160 ROCK inhibitor Y-27632 strongly inhibited the gener-
ation and maintenance of the anchoring structure (Fig. 9 A).
On the other hand, the PI3K inhibitor Ly 294002 only had a
minor effect on the generation of this structure, but moder-
ately inhibited its maintenance (Fig. 9 A). The classical, PKCs
inhibitor Gö6976 did not exert a significant inhibitory effect
neither on the generation nor in the maintenance of the an-
choring structure (Fig. 9 A). Dynamic studies using VCAM-
1–GFP transfected HUVEC showed that the p160 ROCK
inhibitor Y-27632 acted by destroying the docking structure
formed around 4M7 cells, as observed in Fig. 9 B. Finally, the
effect of this inhibitor was assayed on endothelium during pe-
ripheral blood lymphocyte adhesion and transmigration un-
der flow conditions. We found a diminished lymphocyte roll-
ing and adhesion after Y-27632 treatment with regard to
control conditions. Furthermore, some cells that were initially
adhered, began to roll and finally detached from the mono-
layer, indicating an abnormal adhesion process. Accordingly,
all these events led to a significant inhibition of transmigra-
tion. The effect of the inhibitor Y-27632 was analyzed at dif-
ferent time periods (3, 6, 8, and 10 min of perfusion), being
persistent at any time tested, but only the last time is shown,
as representative (Fig. 9 C). Furthermore, immunofluores-
cence analysis revealed that most of adhered lymphocytes were
not tightly anchored by an endothelial docking structure (un-
published data). In conclusion, these findings suggest that
both, PI(4,5)P
 
2
 
 and the Rho/p160 ROCK pathway, are im-
portant for the generation as well as for the maintenance of
the endothelial docking structure.
 
Discussion
 
VCAM-1 is one of the major endothelial receptors that medi-
ates leukocyte adhesion to the vascular endothelium (Carlos
and Harlan, 1994). Recent data obtained with neonatally de-
ficient VCAM-1 mice have strongly suggested that VCAM-1
plays an important role for lymphocyte homing and for T
cell-dependent humoral immune responses (Koni et al., 2001;
Leuker et al., 2001). In addition, VCAM-1 may play an im-
Figure 6.  Formation of the endothelial 
docking structure for adhered 
lymphocytes under flow. 
(A) Transendothelial migration assay of 
peripheral blood lymphocytes under 
fluid shear conditions. After 10 min of 
perfusion, cells were fixed and stained 
for ICAM-1 (b and d, green), VCAM-1 
(c, d, g, and h, red), and ezrin (f and h, 
green). The corresponding DIC images 
are shown in panels a and e. Merged 
images are shown in panels d and h. 
Bar, 3.5  m. (B) Three-dimensional 
reconstruction of VCAM-1 staining 
during 4M7 cell (a), T lymphoblast (b), 
or PBL under flow (c) adhesion.  
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portant role in the pathogenesis of diseases such as atheroscle-
rosis (Cybulsky et al., 2001), rheumatoid arthritis (Carter and
Wicks, 2001), and multiple sclerosis (Alon, 2001). Thus, the
elucidation of VCAM-1 function in leukocyte adhesion and
transmigration is crucial, as this molecule could constitute a
molecular target for therapeutic intervention.
The cytoskeletal components involved in the redistribu-
tion of VCAM-1 at the leukocyte-endothelial cell contact
area have not been studied previously. Among potential can-
didates, ERM proteins seemed likely to mediate this process
as these molecules play an important role in the remodelling
of the plasma membrane, as reported for ICAMs (Helander
et al., 1996; Serrador et al., 1997; Heiska et al., 1998). We
found that endogenous VCAM-1 colocalizes and is physi-
cally associated with moesin and ezrin in microspikes and
microvilli of the apical surface of cytokine-activated endo-
thelial cells. Furthermore, the cytoplasmic tail of VCAM-1
and the active NH
 
2
 
-terminal domain of moesin or ezrin are
capable to directly bind in vitro. These data strongly suggest
that ERM proteins are directly involved in the redistribution
of VCAM-1. However, it cannot be ruled out completely
that adaptor proteins such as EBP50 or E3KARP (Bretscher
et al., 2000), also play a role. It has been reported that ERM
proteins bind to a positively charged amino acid cluster in
the juxta-membrane cytoplasmic domain of CD44, CD43,
and ICAM-2 (Yonemura et al., 1998). In addition, we have
found recently that a novel serine-rich motif within the cy-
toplasmic tail of ICAM-3 is critical for its interaction with
ERM proteins (Serrador et al., 2002). The amino acid se-
quence comparison of VCAM-1 and ICAM-3 cytoplasmic
tails suggests that VCAM-1 contains a similar serine-rich
motif, likely accounting for ERM association.
To study the VCAM-1/ERM interaction during the ex-
travasation of lymphoblasts, we have made extensive use of a
live cell system in combination with time-lapse fluorescence
microscopy and GFP fusion proteins. This afforded us with
information on dynamic relationships of the two molecules
during early adhesion and later stages of TEM. Although both
VCAM-1 and moesin clustered around spreading lympho-
blasts on the apical endothelial surface, only moesin remained
at lymphoblast-endothelial contacts during the passage of
lymphoblasts across the endothelium and their subsequent
migration beneath the endothelial monolayer. However, it has
been reported that VCAM-1 actively participates in T lym-
Figure 7.  Characterization of the 
endothelial docking structure formed 
during leukocyte adhesion. (A) 4M7 cells 
were allowed to adhere to activated 
HUVEC cells, then fixed, permeabilized 
and stained for VCAM-1 (a, green), F-actin 
(b–d, f, and h, red), and tubulin (e and g, 
green). Representative horizontal sections 
of confocal image-stacks are presented 
in a and b and e and f. The panel c 
shows the projection of all the horizontal 
sections corresponding to the image 
presented in a and b. Three-dimensional 
reconstructions of F-actin (d and h) and 
tubulin (g) stainings are also shown. Bars, 
20  m. (B) 4M7 cells adhered to activated 
HUVEC were fixed, permeabilized, and 
stained for talin (a and b, green), VCAM-1 
(a and b, red), or vinculin (c and d, green). 
Representative horizontal sections of 
confocal images are presented in a and 
c. Three-dimensional reconstructions 
are shown in b and d. Bar, 5  m. 
(C) 4M7 cells were allowed to adhere to 
activated HUVEC transfected with 
 -actinin, paxillin-, and VASP-GFP. 
Thereafter, cells were fixed and stained 
with the anti-VCAM-1 mAb P8B1 
(a, d, and f, red). Green signal corresponds 
to GFP fusion proteins (b, c, e, and g). 
Representative horizontal sections of 
confocal image stacks are presented in 
all panels except for c, which shows the 
three-dimensional reconstruction of 
 -actinin–GFP signal. Bars, 5  m. 
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phoblast transmigration across high endothelial venules and
monocyte extravasation (Meerschaert and Furie, 1995; Fa-
veeuw et al., 2000). These discrepancies point to a differential
role of VCAM-1 that might be both leukocyte and endo-
thelial cell-type specific. Our data on moesin dynamics clearly
indicate that another receptor linked to moesin could drive
this migration. In this regard, we have found that the dynamic
behavior of moesin is similar to that of ICAM-1 during lym-
phoblast transmigration, a finding that is in accordance with
previous reports describing the distribution of ICAM-1 on the
lumenal and basal surfaces of the endothelium and its involve-
ment in TEM (Oppenheimer-Marks et al., 1991; Randolph
and Furie, 1996). The differential dynamic behavior of
VCAM-1 and ICAM-1 during lymphoblast adhesion and
transmigration on the one hand, and of moesin on the other,
could suggest a mechanism by which ERM proteins are able
to regulate the distribution of both molecules independently.
As VCAM-1/ERM interaction was mostly restricted to
leukocyte tight adhesion and spreading, we took advantage of
a cellular model based mainly on VLA-4/VCAM-1. In this
model, leukocytes are restricted to a sustained tight adhesion
and are unable to progress to TEM, allowing a detailed study
of the endothelial VCAM-1/ERM interaction. In this cell
model, VCAM-1 and both, moesin and ezrin, clustered
around adherent leukocytes, participating in the formation of
an actin-rich docking structure that was attached to and par-
tially engulfed the leukocyte. Similar docking structures were
formed around spreading lymphoblasts in static conditions
or PBLs adhered to endothelium under flow, in which
VCAM-1 and ICAM-1 were concentrated together with
ERM proteins. The fact that both adhesion receptors actively
participate in such endothelial structure would reinforce the
concept of cross-talk between their ligands VLA-4 and LFA-1
Figure 8.  Localization of phosphorylated ERM 
proteins and phosphoinositides at the anchoring 
structure. (A) 4M7 cells adhered to activated 
HUVEC were fixed, permeabilized and stained 
with the mAb 297S. Representative horizontal 
section of a confocal micrograph (a), and a three-
dimensional reconstruction of a series of horizontal 
sections (b) are shown. Bar, 5  m. (B) HUVEC cells 
were transfected with PLCs-PH- and GRP1-PH-GFP 
and then, 4M7 cells were allowed to adhere. 
Thereafter, cells were fixed, permeabilized and 
stained with the anti-VCAM-1 mAb P8B1 (a and d). 
Green signal corresponds to GFP fusion proteins 
(b and e). Panels c and f show three-dimensional 
reconstructions of horizontal sections corresponding 
to the green signal. Bars, 5  m. 
Figure 7 (continued) 
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during lymphocyte adhesion (Chan et al., 2000; Rose et al.,
2001). Under these physiological conditions, docking struc-
tures rapidly vanished as lymphoblasts or lymphocytes began
to migrate through the endothelial monolayer.
Our findings highlight the remarkable active role played by
the endothelium during leukocyte adhesion. Thus, the initial
VCAM-1 and ICAM-1 engagement trigger their clustering
and the subsequent activation and clustering of endothelial
Figure 9.  Rho/p160 ROCK pathway regulates the generation and maintenance of the VCAM-1–mediated docking structure. (A) Activated 
HUVEC were pretreated with Y27632 (30  M), Ly294002 (20  M), or Gö6976 (1  M) for 20 min before or 30 min after the addition of 4M7 
cells. Total adhesion time was in both cases 60 min. Quantification of leukocyte adhesion and endothelial docking structure formation was 
carried out by staining with the mAb anti–VCAM-1 P8B1 and counting 300 adhered cells of each treatment. A representative experiment out 
of four independent ones is presented. (B) Kinetics of the endothelial anchoring structure dissolution after the addition of the p160 ROCK 
inhibitor Y-27632. The inhibitor Y-27632 (30  M) was added after the formation of the docking structure in a 4M7 adhesion assay performed 
as above. Representative horizontal sections captured every 15 min are shown in a–d. DIC and fluorescence images are merged and 
presented in the lower side of each panel. Arrows indicate the clustering of GFP proteins. Bar, 10  m. (C) Effect of Y-27632 on peripheral 
blood lymphocyte adhesion and TEM under flow conditions. Activated endothelium was pretreated or not with Y-27632 (30  M) for 30 min. 
Thereafter, PBLs were allowed to adhere and transmigrate under flow conditions for 10 min. Quantification of rolling (R), adhesion (A), 
transmigration (T), and detachment (D) events during the last minute of perfusion was carried out. Values correspond to the arithmetic
mean   SD of four different fields belonging to a representative experiment. Statistically significant values, as defined by unpaired Student’s t 
test, are indicated with *(P   0.01) or **(P   0.002) compared with no inhibitory treatment. Adhesion receptor/ERM docking structure for leukocytes | Barreiro et al. 1243
moesin and ezrin at the site of cell–cell contact. In turn, phos-
phorylated active ERM proteins would participate in concert
with  -actinin, an actin-bundling protein, in the rearrange-
ment of the actin cytoskeleton to create the docking structure.
Several focal adhesion proteins such as vinculin, talin, and
paxillin seem to be involved as well. Interestingly, the endo-
thelial docking structure is reminiscent of nascent receptor-
mediated phagosomes, in that the subcellular distribution of
all these structural proteins is similar in both structures (Allen
and Aderem, 1996). In this regard, it has been proposed that
focal adhesions and complement receptor-mediated phago-
somes could share some conserved mechanisms requiring the
same molecules (May and Machesky, 2001). A similar argu-
ment could be made to functionally link the former structures
and the novel leukocyte–endothelium docking structure de-
scribed here. On the other hand, VASP is concentrated in the
docking structure. This protein is present in actin-based pro-
trusions, where it cooperates with WASp-Arp2/3 complex, as
occurs in phagosomes (Castellano et al., 2001). Its presence at
the docking structure could indicate the existence of actin po-
lymerization supporting this endothelial structure, and sug-
gests common mechanisms for de novo actin assembly in all
these structures. Interestingly, ERM proteins have been also
implicated in the de novo actin assembly on mature Fc recep-
tor-mediated phagosomes (Defacque et al., 2000).
As ERM activation occurred during the formation of the
anchoring structure, we studied the regulatory mechanisms
involved. These proteins are regulated by the interplay of
PI(4,5)P2 metabolism and components of the Rho GTPase
signaling pathway, thereby linking events occurring at the
plasma membrane with cytoskeletal remodelling (Sechi and
Wehland, 2000). Interestingly, these regulatory molecules are
also important in phagocytosis (Botelho et al., 2000; Chimini
and Chavrier, 2000). We found that PI(3,4)P2, PI(3,4,5)P3,
and more abundantly PI(4,5)P2, colocalized with VCAM-1 and
ERM proteins in the endothelial docking structure. Nota-
bly, PI(4,5)P2 was preferentially concentrated at the mi-
crospike tips, whereas the other phosphoinositides exhibited a
more diffuse pattern. These observations point to a prominent
role of PI(4,5)P2 in regulating molecular events during endo-
thelial docking of leukocytes. One such event could be the ac-
tivation of moesin and ezrin through its binding to their
NH2-terminal domain. PI(4,5)P2 production could be medi-
ated by Rho, as PI4P5K is a down-stream RhoGTPase effec-
tor. On the other hand, the presence of PI(3,4)P2 and
PI(3,4,5)P3 could be related to PI3K activity. Inhibitors of
PI3K only mildly affected the generation and maintenance of
the docking structure, a finding that is in agreement with its
role in phagocytosis, namely to mediate phagosome closure
(Cox et al., 1999). In our experimental model, the endothelial
anchoring structure does not progress to engulf the leukocyte;
therefore, it is less PI3K dependent. In contrast, the p160
ROCK inhibitor Y27632 inhibited the formation of the an-
choring structure and induced its dissolution as well. Abnor-
mal formation of the endothelial docking structure was also
observed under flow conditions after the treatment with
Y-27632, which rendered an inhibitory effect in lymphocyte
adhesion and transmigration. In addition, the phenomenon of
rolling was also decreased. This finding is in agreement with
previous reports describing the existence of an E-selectin/actin
cytoskeleton adhesion complex induced by leukocyte adhe-
sion (Yoshida et al., 1996; Lorenzon et al., 1998), which it is
likely to be also affected by the inhibition of the Rho/p160
ROCK pathway. Our results concur with the previously de-
scribed regulation of the VCAM-1, ICAM-1, and E-selectin
clustering by the GTPase Rho during monocyte adhesion
(Wojciak-Stothard et al., 1999). Furthermore, the key role of
the Rho/p160 ROCK signaling pathway in the regulation of
the adhesion receptor/ERM/actin cytoskeleton interaction
and remodelling, which results in the formation of this pro-
trusive structure, is further strengthened by the implication of
this pathway in the regulation of complement receptor–medi-
ated phagosomes (Caron and Hall, 1998).
In conclusion, our results provide novel insights into the
links between the actin cytoskeleton and adhesion receptors
involved in leukocyte adhesion and TEM during inflamma-
tion. Further analysis will be focused on molecules involved
in the regulation of the endothelial docking structure dis-
ruption to allow diapedesis, and the signaling pathways that
interconnect both processes.
Materials and methods
Cells and cell cultures
HUVEC were obtained and cultured as previously described (Yáñez-Mó et
al., 1998). Cells were used up to the third passage in all assays. To activate
HUVEC, TNF-  (20 ng/m; R&D Systems) was added to the culture media
20 h before the assays were performed. Human PBLs and T lymphoblasts
were obtained and cultured as described elsewhere (Serrador et al., 1997).
K562 cells stably transfected with the  4 integrin chain gene (4M7 cells) were
grown in RPMI 1640 medium (GIBCO BRL) supplemented with 10% FCS, 50
IU/ml penicillin, 50  g/ml streptomycin, and 1 mg/ml of G418 (Calbiochem).
Antibodies and reagents
The TEA1/31 anti-VE cadherin and TS2/16 anti- 1 integrin (Yáñez-Mó et al.,
1998), the HP2/1 anti- 4 integrin, TS1/11 anti- L integrin, and TP1/24 anti-
ICAM-3 (Serrador et al., 1997) mAb have been described elsewhere. The 4B9
and P8B1 (anti–VCAM-1), Hu5/3 (anti–ICAM-1), and 297S (antiphosphory-
lated forms of ERM proteins) mAb were provided by Dr. R.R. Lobb (Biogen
Inc.), Dr. E.A. Wayner (Fred Hutchinson Cancer Research Center, Seattle,
WA), Dr. F.W. Luscinskas (Brigham and Women’s Hospital and Harvard
Medical School, Boston, MA), and Dr. S. Tsukita (Faculty of Medicine, Kyoto
University, Japan), respectively. The moesin-specific polyclonal antiserum
95/2 and the ezrin-polyclonal antiserum 90/3 have been previously described
(Serrador et al., 2002). The anti-tubulin and -vinculin mAb were purchased
from Sigma-Aldrich. The anti-talin polyclonal antibody (pAb) was a gift of Dr.
K. Burridge (University of North Carolina, Chapel Hill, NC). The monoclonal
IgG1,  from the P3 63 myeloma cell line was used as negative control. Re-
combinant human fibronectin was purchased from Sigma-Aldrich. The p160
ROCK inhibitor Y-27632, the PI3K inhibitor Ly 294002, and the classical
PKCs inhibitor Gö6976 were purchased from Calbiochem.
Recombinant DNA constructs and cell transfections
The fusion protein GST–VC, containing the cytoplasmic tail of VCAM-1, was
obtained by PCR amplification using as template the human VCAM-1
cDNA, and [TATGGATCCAGAAAAGCCAACATGAAG] and [TGGAAT-
TCATAGATGGGCATTTC] as 5  and 3  primers, respectively. The PCR prod-
uct was cloned as a BamHI/EcoRI fragment into pGEX-4T (Pharmacia LKB
Biotechnology). The cytoplasmic tail of ICAM-3 fused to GST (GST-IC3), and
a truncated form of it (GST-Y9, Y490stop) have been described elsewhere
(Serrador et al., 2002). Expression of GST fusion proteins in BL21 bacteria
and purification were performed following the manufacturer’s instructions.
VCAM-1–GFP and ICAM-1–GFP were obtained using the correspond-
ing human cDNAs as templates to amplify by PCR the complete encoding
region of these molecules without the stop codon. A Xho I site was added
to the 5  end and a Xma I site at the 3  end of VCAM-1 cDNA. Likewise,
HindIII and BamHI sites were added to the 5  and 3  ends of ICAM-1
cDNA, respectively. The PCR products were then cloned into pEGFP-N1
(CLONTECH Laboratories, Inc.) resulting in an in-frame fusion of en-
hanced GFP to the COOH terminus of VCAM-1 and ICAM-1. The VCAM-1-1244 The Journal of Cell Biology | Volume 157, Number 7, 2002
and ICAM-1–GFP proteins behaved similarly to the corresponding endoge-
nous proteins in terms of their binding to ezrin and moesin. The generation
of the GFP fusion construct containing the GFP cDNA inserted at the
COOH-terminal end of the rat full-length moesin (moesin-GFP, residues
1–577) has been previously described (Amieva et al., 1999).  -actinin–
GFP and paxillin-GFP were gifts of Dr. A.F. Horwitz (University of Vir-
ginia, Charlottesville, VA). VASP-GFP, PLC -PH-GFP, and GRP1-PH-GFP,
were provided by Dr. J.V. Small (Institute of Molecular Biology, Salzburg,
Austria), Dr. T. Balla (National Institutes of Health, Bethesda, MA), and Dr.
A. Gray (University of Dundee, Dundee, U.K.), respectively.
Transiently transfected HUVEC were generated by electroporation at 200 V
and 975  F using a Gene Pulser (Bio-Rad Laboratories) and adding 20  g of
each DNA construct. These cells were used 24–48 h after transfection.
Flow cytometry analysis, immunofluorescence, and 
confocal microscopy
For flow cytometry analysis and immunofluorescence experiments, cells were
treated as previously described (Yáñez-Mó et al., 1998). Rhodamine Red-
X-Affinipure goat anti–mouse IgG (H L), Alexa Fluor 488 rabbit anti–mouse
or goat anti–rabbit IgG (H   L) conjugate highly crossadsorbed, Alexa Fluor
488 streptavidin, and Phalloidin Alexa Fluor 568 were used as fluorescent re-
agents (Molecular Probes). Staining with the 297S mAb was performed as pre-
viously described (Hayashi et al., 1999). Series of optical sections were ob-
tained with a Leica TCS-SP confocal laser scanning unit equipped with Ar and
He/Ne laser beams and attached to a Leica DMIRBE inverted epifluorescence
microscope (Leica Microsystems), using a 63  oil immersion objective. Colo-
calization histograms were obtained using the Leica Confocal Software.
Immunoprecipitation, Western blot, in vitro translation, and 
protein binding assays
Lysates from activated HUVEC, immunoprecipitation, and Western blot
were performed as described (Serrador et al., 2002). The pCR3 plasmids
carrying the inserts of untagged moesin and ezrin NH2-terminal regions
(amino acid residues 1–310) were transcribed, translated, and isotope la-
beled in vitro using a TNT-coupled rabbit reticulocyte lysate system
(Promega). Then, binding assays using these isotope-labeled recombinant
proteins and the GST fusion proteins (GST–VC, GST–IC3, GST–Y9, and
GST alone) were performed as previously described (Serrador et al., 2002).
Adhesion and transendothelial migration assays
For cellular adhesion assays, HUVEC were grown to confluence in 96-
microwell plates (Costar) and activated with TNF-  for 20 h. K562 cells were
labeled with 1  M of BCECF-AM for 15 min at 37 C, preincubated with
different purified mAb, and allowed to adhere to activated HUVEC for 15
min at 37 C as previously described (Yáñez-Mó et al., 1998). Fluorescence
intensity was measured in a microplate reader (Biotek FL500). T lympho-
blast migration through a confluent monolayer of activated HUVEC was
assayed in 3- m pore Transwell cell culture chambers (Costar). HUVEC
were seeded and grown to confluence on these Transwell inserts pre-
coated with 1% gelatin and activated with TNF-  for 20 h. Cultured lym-
phoblasts (2   10
5 in 100  l of complete 199 medium/well) were incu-
bated with 10  g/ml of different purified mAbs for 20 min at 4 C, and then
added to the upper chambers. In the lower well, 600  l of complete 199
medium were poured. Cells were incubated for 90 min at 37 C, and mi-
grated cells were recovered from the lower chamber. The relative number
of migrated cells was estimated by flow cytometry.
Time-lapse fluorescence confocal microscopy
HUVEC transfected with different GFP constructs were grown to conflu-
ence on glass-bottom dishes (WillCo Wells) precoated with Fn (20  g/ml).
Then, cells were activated with TNF-  for 20 h, and placed on the micro-
scope stage. 4M7 cells or T lymphoblasts resuspended in 500  l of com-
plete 199 medium were added. Plates were maintained at 37 C in a 5%
CO2 atmosphere using an incubation system (La-con GBr Pe-con GmbH).
Confocal series of fluorescence and differential interference contrast (DIC)
images, distanced 0.4  m in the z axis, were simultaneously obtained at
30-s or 1-min intervals, with a 63  oil immersion objective. Images were
processed and assembled into movies using the Leica Confocal Software.
Parallel plate flow chamber analysis of 
endothelial-PMN interactions
The parallel plate flow chamber used for leukocyte adhesion and transmi-
gration under defined laminar flow has been described in detail (Luscinskas
et al., 1994). PBLs (10
6/ml) were drawn across activated confluent mono-
layers at an estimated wall shear stress of 1.8 dynes/cm
2 for perfusion times
from 30 s to 10 min. Lymphocyte rolling on the endothelium were easily vi-
sualized as they travelled more slowly than free-flowing cells. Lymphocytes
were considered to be adherent after 20 s of stable contact with the mono-
layer. Transmigrated lymphocytes were determined as being beneath the
endothelial monolayer. Lymphocytes were considered to be detached
when they returned to free-flowing after having been completely arrested
on endothelium. The number of rolling, adhered, transmigrated, and de-
tached cells was quantified by direct visualization of 4 different fields (40 
phase-contrast objective) at each time point of every independent experi-
ment. Coverslips were fixed immediately in PFA 4% at room temperature
for 10 min, washed with HBSS, and stained for VCAM-1, ICAM-1, or ezrin.
Online supplemental material
All videos are available at http://www.jcb.org/cgi/content/full/
jcb.200112126/DC1. Video 1 (corresponding to Fig. 4 A, a–f) shows a
lymphoblast that contacts with a moesin–GFP-transfected endothelial cell,
and immediately transmigrates and moves beneath the endothelium.
Moesin is clustered around the lymphoblast along the whole process.
Video 2 (corresponding to Fig. 4 A, g–l), shows a lymphoblast (upper site)
that adheres to, spreads on, and moves toward a lateral junction of the
VCAM-1–GFP-transfected endothelial cell. It then transmigrates and
moves beneath the endothelium, whereas another lymphoblast (lower site)
remains spread on the endothelial cell. VCAM-1 is clustered around lym-
phoblasts adhered to the apical surface of endothelium (arrows), but it is
not concentrated around migrating lymphocytes beneath the endothelium
(arrowheads). Video 3 (corresponding to Fig. 4 B), shows a lymphoblast
that adheres to, spreads on, and moves toward a lateral junction of the
ICAM-1–GFP-transfected endothelial cell (black arrows). It then transmi-
grates and moves beneath the endothelium (white arrows). ICAM-1 is clus-
tered around the lymphoblast along the whole process. In all videos, the
apical endothelial surface is at a plane remote from the observer.
We thank Drs. R. González-Amaro, D. Sancho, and P. Roda-Navarro for
critical reading of the manuscript.
This work was supported by grants SAF99-0034-C01 and FEDER
2FD97-068-C02-02 from the Ministerio de Educación, and grant QLRT-
1999-01036 from the European Community to F. Sánchez-Madrid, and a
fellowship from the Ministerio de Educación to O. Barreiro.
Submitted: 24 December 2001
Revised: 7 May 2002
Accepted: 7 May 2002
References
Allen, L.-A.H., and A. Aderem. 1996. Molecular definition of distinct cytoskeletal
structures involved in complement- and Fc receptor-mediated phagocytosis
in macrophages. J. Exp. Med. 184:627–637.
Alon, R. 2001. Encephalitogenic lymphoblast recruitment to resting CNS mi-
crovasculature: a natural immunosurveillance mechanism? J. Clin. Invest.
108:517–519.
Amieva, M.R., P. Litman, L. Huang, E. Ichimaru, and H. Furthmayr. 1999. Dis-
ruption of dynamic cell surface architecture of NIH3T3 fibroblasts by the
N-terminal domains of moesin and ezrin: in vivo imaging with GFP fusion
proteins. J. Cell Sci. 112:111–125.
Barret, C., C. Roy, P. Montcourrier, P. Mangeat, and V. Niggli. 2000. Mutagene-
sis of the phosphatidilinositol 4,5-biphosphate (PIP[2]) binding site in the
NH(2)-terminal domain of ezrin correlates with its altered cellular distribu-
tion. J. Cell Biol. 151:1067–1079.
Botelho, R.J., M. Teruel, R. Dierckman, R. Anderson, A. Wells, J.D. York, T.
Meyer, and S. Grinstein. 2000. Localized biphasic changes in phosphatidyl-
inositol-4,5-biphosphate at sites of phagocytosis. J. Cell Biol. 151:1353–1367.
Bretscher, A., D. Chambers, R. Nguyen, and D. Reczek. 2000. ERM-Merlin and
EBP50 protein families in plasma membrane organization and function.
Annu. Rev. Cell Dev. Biol. 16:113–143.
Butcher, E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps
to specificity and diversity. Cell. 67:1033–1036.
Carlos, T.M., and J.M. Harlan. 1994. Leukocyte-endothelial adhesion molecules.
Blood. 84:2068–2101.
Caron, E., and A. Hall. 1998. Identification of two distinct mechanisms of phago-
cytosis controlled by different Rho GTPases. Science. 282:1717–1721.
Carter, R.A., and I.P. Wicks. 2001. Vascular cell adhesion molecule 1 (CD 106). A
multifaceted regulator of joint inflammation. Arthritis Rheum. 44:985–994.
Castellano, F., C. Le Clainche, D. Patin, M.-F. Carlier, and P. Chavrier. 2001. A
WASp-VASP complex regulates actin polymerization at the plasma mem- Adhesion receptor/ERM docking structure for leukocytes | Barreiro et al. 1245
brane. EMBO J. 20:5603–5614.
Chan, J.R., S.J. Hyduk, and M.I. Cybulsky. 2000.  4 1 integrin/VCAM-1 inter-
action activates  L 2 integrin-mediated adhesion to ICAM-1 in human T
cells. J. Immunol. 164:746–753.
Cox, D., C.C. Tseng, G. Bjekic, and S. Greenberg. 1999. A requirement for phosphati-
dylinositol 3-kinase in pseudopod extension. J. Biol. Chem. 274:1240–1247.
Cybulsky, M.I., K. Iiyama, H. Li, S. Zhu, M. Chen, M. Iiyama, V. Davis, J.C.
Gutierrez-Ramos, P.W. Connelly, and D.S. Milstone. 2001. A major role
for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:
1255–1262.
Chimini, G., and P. Chavrier. 2000. Function of Rho family proteins in actin dy-
namics during phagocytosis and engulfment. Nat. Cell Biol. 2:E191–E196.
Defacque, H., M. Egeberg, A. Habermann, M. Diakonova, C. Roy, P. Mangeat,
W. Voelter, G. Marriot, J. Pfannstiel, H. Faulstich, and G. Griffiths. 2000.
Involvement of ezrin/moesin in de novo actin assembly on phagosomal
membranes. EMBO J. 19:199–212.
Doi, Y., M. Itoh, S. Yonemura, S. Ishihara, H. Takano, T. Noda, and S. Tsukita.
1999. Normal development of mice and unimpaired cell adhesion/cell mo-
tility/actin-based cytoskeleton without compensatory up-regulation of ezrin
or radixin in moesin gene knockout. J. Biol. Chem. 274:2315–2321.
Elices, M.J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M.E. Hemler, and
R.R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leu-
kocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding
site. Cell. 60:577–584.
Faveeuw, C., M.E. Di Mauro, A.A. Price, and A. Ager. 2000. Roles of alpha(4) in-
tegrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial
migration of T lymphocytes and T lymphoblasts across high endothelial
venules. Int. Immunol. 12:241–251.
González-Amaro, R., and F. Sánchez-Madrid. 1999. Cell adhesion molecules: se-
lectins and integrins. Crit. Rev. Immunol. 19:389–429.
Gray, A., J. van der Kaay, and C.P. Downes. 1999. The pleckstrin homology do-
mains of protein kinase B and GRP1 (general receptor for phosphoinosi-
tides-1) are sensitive and selective probes for the cellular detection of
phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-
triphosphate in vivo. Biochem. J. 344:929–936.
Hayashi, K., S. Yonemura, T. Matsui, and S. Tsukita. 1999. Immunofluorescence
detection of ezrin/radixin/moesin (ERM) proteins with their carboxil-termi-
nal threonine phosphorylated in cultured cells and tissues. J. Cell Sci. 112:
1149–1158.
Heiska, L., K. Alfthan, M. Gronholm, P. Vilja, A. Vaheri, and O. Carpen. 1998.
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1
and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J.
Biol. Chem. 273:21893–21900.
Helander, T.S., O. Carpen, O. Turunen, P.E. Kovanen, A. Vaheri, and T. Ti-
monen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Na-
ture. 382:265–268.
Hirao, M., N. Sato, T. Kondo, S. Yonemura, M. Monden, T. Sasaki, Y. Takai, and
S. Tsukita. 1996. Regulation mechanism of ERM (ezrin/radixin/moesin) pro-
tein/plasma membrane association: possible involvement of phosphatidylinosi-
tol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:37–51.
Koni, P.A., S.K. Joshi, U.A. Temann, D. Olson, L. Burkly, and R.A. Flavell. 2001.
Conditional vascular cell adhesion molecule 1 deletion in mice: impaired
lymphocyte migration to bone marrow. J. Exp. Med. 193:741–753.
Leuker, C.E., M. Labow, W. Müller, and N. Wagner. 2001. Neonatally induced
inactivation of the vascular cell adhesion molecule 1 gene impairs B cell lo-
calization and T cell-dependent humoral immune response. J. Exp. Med.
193:755–767.
Lorenzon, P., E. Vecile, E. Nardon, E. Ferrero, J.M. Harlan, F. Tedesco, and A.
Dobrina. 1998. Endothelial cell E- and P-selectin and vascular cell adhesion
molecule-1 function as signaling receptors. J. Cell Biol. 142:1381–1391.
Luscinskas, F.W., G.S. Kansas, H. Ding, P. Pizcueta, B.E. Schleiffenbaum, T.F.
Tedder, and M.A. Gimbrone Jr. 1994. Monocyte rolling, arrest and spread-
ing on IL-4 activated vascular endothelium under flow is mediated via se-
quential action of L-selectin, beta-1-integrins, and beta-2-integrins. J Cell
Biol. 125:1417–1427. 
Mangeat, P., C. Roy, and M. Martin. 1999. ERM proteins in cell adhesion and
membrane dynamics. Trends Cell Biol. 9:187–192.
Marlin, S.D., and T.A. Springer. 1987. Purified inter-cellular adhesion molecule
(ICAM-1) is a ligand for lymphocyte-associated antigen 1 (LFA1). Cell. 51:
813–819.
Matsui, T., M. Maeda, Y. Doi, S. Yonemura, M. Amano, K. Kaibuchi, and S. Tsu-
kita. 1998. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/
radixin/moesin (ERM) proteins and regulates their head-to-tail association.
J. Cell Biol. 140:647–657.
May, R.C., and L.M. Machesky. 2001. Phagocytosis and the actin cytoskeleton. J.
Cell Sci. 114:1061–1077.
Meerschaert, J., and M.B. Furie. 1995. The adhesion molecules used by monocytes
for migration across endothelium include CD11a/CD18, CD11b/CD18,
and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on en-
dothelium. J. Immunol. 154:4099–4112.
Menager, C., J. Vassy, C. Doliger, Y. Legrand, and A. Karniguian. 1999. Subcellular
localization of RhoA and ezrin at membrane ruffles of human endothelial cells:
differential role of collagen and fibronectin. Exp. Cell Res. 249:221–230.
Muñoz, M., J. Serrador, F. Sanchez-Madrid, and J. Teixido. 1996. A region of the
integrin VLA alpha 4 subunit involved in homotypic cell aggregation and in
fibronectin but not vascular cell adhesion molecule-1 binding. J. Biol. Chem.
271:2696–2702.
Nakamura, F., L. Huang, K. Pestonjamasp, E.J. Luna, and H. Furthmayr. 1999.
Regulation of F-actin binding to platelet moesin in vitro by both phosphor-
ylation of threonine 558 and polyphosphatidylinositides. Mol. Biol. Cell. 10:
2669–2685.
Oppenheimer-Marks, N., L.S. Davis, D.T. Bogue, J. Ramberg, and P.E. Lipsky.
1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion
and transendothelial migration of human T lymphocytes. J. Immunol. 147:
2913–2921.
Randolph, G.J., and M.B. Furie. 1996. Mononuclear phagocytes egress from an in
vitro model of the vascular wall by migrating across endothelium in the basal
to apical direction: role of intercellular adhesion molecule 1 and the CD11/
CD18 integrins. J. Exp. Med. 183:451–462.
Rose, D.M., V. Grabovsky, R. Alon, and M.H. Ginsberg. 2001. The affinity of in-
tegrin  4 1 governs lymphocyte migration. J. Immunol. 167:2824–2830.
Sechi, A.S., and J. Wehland. 2000. The actin cytoskeleton and plasma membrane
connection: PtdIns(4,5)P2 influences cytoskeletal protein activity at the
plasma membrane. J. Cell Sci. 113:3685–3695.
Serrador, J.M., J.L. Alonso-Lebrero, M.A. del Pozo, H. Furthmayr, R. Schwartz-
Albiez, J. Calvo, F. Lozano, and F. Sánchez-Madrid. 1997. Moesin interacts
with the cytoplasmic region of intercellular adhesion molecule-3 and is redis-
tributed to the uropod of T lymphocytes during cell polarization. J. Cell
Biol. 138:1409–1423.
Serrador, J.M., M. Vicente-Manzanares, J. Calvo, O. Barreiro, M.C. Montoya, R.
Schwartz-Albiez, H. Furthmayr, F. Lozano, and F. Sanchez-Madrid. 2002.
A novel serine-rich motif in the intercellular adhesion molecule-3 is critical
for its ERM-directed subcellular targeting. J. Biol Chem. 277:10400–10409.
Shaw, R.J., M. Henry, F. Solomon, and T. Jacks. 1998. RhoA-dependent phos-
phorylation and relocalization of ERM proteins into apical membrane/actin
protrusions in fibroblasts. Mol. Biol. Cell. 9:403–419.
Takahashi, K., T. Sasaki, A. Mammoto, K. Takaishi, T. Kameyama, S. Tsukita,
and Y. Takai. 1997. Direct interaction of the Rho GDP dissociation inhibi-
tor with ezrin/radixin/moesin initiates the activation of the Rho small G pro-
tein. J. Biol. Chem. 272:23371–23375.
Turunen, O., T. Wahlstrom, and A. Vaheri. 1994. Ezrin has a COOH-terminal
actin-binding site that is conserved in the ezrin protein family. J. Cell Biol.
126:1445–1453.
Várnai, P., K.I. Rother, and T. Balla. 1999. Phosphatidylinositol 3-kinase-dependent
membrane association of the Bruton’s tyrosine kinase pleckstrin homology do-
main visualized in single living cells. J. Biol. Chem. 274:10983–10989.
Wojciak-Stothard, B., L. Williams, and A.J. Ridley. 1999. Monocyte adhesion and
spreading on human endothelial cells is dependent on Rho-regulated recep-
tor clustering. J. Cell Biol. 145:1293–1307.
Yáñez-Mó, M., A. Alfranca, C. Cabañas, M. Marazuela, R. Tejedor, M.A. Ursa,
L.K. Ashman, M.O. de Landázuri, and F. Sánchez-Madrid. 1998. Regula-
tion of endothelial cell motility by complexes of tetraspan molecules CD81/
TAPA-1 and CD151/PETA-3 with alpha3beta1 integrin localized at endo-
thelial lateral junctions. J. Cell Biol. 141:791–804.
Yonemura, S., M. Hirao, Y. Doi, N. Takahashi, T. Kondo, and S. Tsukita. 1998.
Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino
acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43,
and ICAM-2. J. Cell Biol. 140:885–895.
Yonemura, S., and S. Tsukita. 1999. Direct involvement of ezrin/radixin/moesin
(ERM)-binding membrane proteins in the organization of microvilli in col-
laboration with activated ERM proteins. J. Cell Biol. 145:1497–1509.
Yoshida, M., W.F. Westlin, N. Wang, D.E. Ingber, A. Rosenzweig, N. Resnick, and
M.A.J. Gimbrone. 1996. Leukocyte adhesion to vascular endothelium induces
E-selectin linkage to the actin cytoskeleton. J. Cell Biol. 133:445–455.